Hikari Tsushin, Inc. Royalty Pharma PLC Transaction History
Hikari Tsushin, Inc.
- $1.35 Billion
- Q4 2024
A detailed history of Hikari Tsushin, Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Hikari Tsushin, Inc. holds 2,220 shares of RPRX stock, worth $72,061. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,220
Previous 2,220
-0.0%
Holding current value
$72,061
Previous $62,000
9.68%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RPRX
# of Institutions
424Shares Held
285MCall Options Held
566KPut Options Held
36.2K-
Morgan Stanley New York, NY41.1MShares$1.33 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.21 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$747 Million0.01% of portfolio
-
Baillie Gifford & CO14.1MShares$459 Million0.28% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$395 Million0.39% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.2B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...